<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    American International Holdings Corp.

    American International Holdings Corp.

    American International Industries, Inc. (OTCQB: AMIN) is a diversified holding com...

    American International Industries, Inc. (OTCQB:...

    Filing Type:    RA
    Generex Biotechnology Corp.

    Generex Biotechnology Corp.

    Generex Biotechnology is an integrated healthcare holding company with end-to-end ...

    Generex Biotechnology is an integrated healthca...

    Filing Type:    PU
    Cerus Corporation

    Cerus Corporation

    Cerus Corporation is dedicated solely to safeguarding the world’s blood supply a...

    Cerus Corporation is dedicated solely to safegu...

    Filing Type:    PU
    Delee Corp

    Delee Corp

    At Delee we’re fundamentally changing not only the way cancer is detected but also...

    At Delee we’re fundamentally changing not only ...

    Amount Raised:    $492,503.00
    Fundraising Status:    EC
    Filing Type:    CF
    Virtuoso Surgical, Inc.

    Virtuoso Surgical, Inc.

    Virtuoso Surgical, Inc. was born out of a collaborative research effort developing...

    Virtuoso Surgical, Inc. was born out of a colla...

    Filing Type:    RA
    Kaleido Biosciences, Inc.

    Kaleido Biosciences, Inc.

    Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, ...

    Kaleido Biosciences is a clinical-stage healthc...

    Filing Type:    PU
    Nephros, Inc.

    Nephros, Inc.

    Nephros is a commercial stage company that develops and sells high performance wat...

    Nephros is a commercial stage company that deve...

    Filing Type:    PU
    InnaMed, Inc.

    InnaMed, Inc.

    InnaMed is developing a comprehensive care management platform. Our team is develo...

    InnaMed is developing a comprehensive care mana...

    Amount Raised:    $1,070,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    IntriCon Corporation

    IntriCon Corporation

    For more than 40 years, IntriCon has been meeting the rising demand for smaller, p...

    For more than 40 years, IntriCon has been meeti...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.